# From darkness to light: Case report on afamelanotide-treatment in a 9-year-old child with erythropoietic protoporphyria.

> PubMed lists PMID 41542313 in JAAD case reports as Case Reports, Journal Article, with publication-date metadata of 2025-11-24 (day precision). PeptideScanner associated the retained record with the identity slug afamelanotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-41542313-afamelanotide:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-01-18
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-41542313-afamelanotide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-41542313-afamelanotide-v1.json
- Content SHA-256: `ee0e81bf3a8ae55e3cd5d712991b2dc64d59cc2163e1fcab817b3cfc3971f2b7`

## Claims and source pins

### Headline

From darkness to light: Case report on afamelanotide-treatment in a 9-year-old child with erythropoietic protoporphyria. ([`pubmed-observation-pmid-41542313-2026-01-18-6d36ea5ea300`](#source-pubmed-observation-pmid-41542313-2026-01-18-6d36ea5ea300))

### Summary

PubMed lists PMID 41542313 in JAAD case reports as Case Reports, Journal Article, with publication-date metadata of 2025-11-24 (day precision). PeptideScanner associated the retained record with the identity slug afamelanotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-41542313-2026-01-18-6d36ea5ea300`](#source-pubmed-observation-pmid-41542313-2026-01-18-6d36ea5ea300))

### Paragraph 1

PubMed lists PMID 41542313 in JAAD case reports as Case Reports, Journal Article, with publication-date metadata of 2025-11-24 (day precision). PeptideScanner associated the retained record with the identity slug afamelanotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-41542313-2026-01-18-6d36ea5ea300`](#source-pubmed-observation-pmid-41542313-2026-01-18-6d36ea5ea300))

### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-41542313-2026-01-18-6d36ea5ea300`](#source-pubmed-observation-pmid-41542313-2026-01-18-6d36ea5ea300))

## Sources

<a id="source-pubmed-observation-pmid-41542313-2026-01-18-6d36ea5ea300"></a>
- **From darkness to light: Case report on afamelanotide-treatment in a 9-year-old child with erythropoietic protoporphyria. · retained source version 1:2026-01-18:current:6d36ea5ea3000b5566b3cd7c47b4dcc0e76d40ac9ffdc26ed668f8090e154a84** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/41542313/) (`pubmed-observation-pmid-41542313-2026-01-18-6d36ea5ea300`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "From darkness to light: Case report on afamelanotide-treatment in a 9-year-old child with erythropoietic protoporphyria." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-41542313-afamelanotide-v1.json SHA-256: ee0e81bf3a8ae55e3cd5d712991b2dc64d59cc2163e1fcab817b3cfc3971f2b7.